Endocrine & Metabolic Focused Research
Leverage Omega Research's cross-functional expertise in Endocrinology & Metabolism to enhance the efficiency and impact of your clinical development and real-world evidence programs.
Establishing Efficiencies in Endocrine & Metabolic Research
Endocrine and Metabolic diseases represent a rapidly expanding frontier in clinical research. The high demand for novel therapies faces challenges in patient recruitment, complex trial design, and the need for robust safety data.
Omega Research successfully navigates these operational and regulatory complexities with deep therapeutic expertise and a proven track record in both interventional trials and observational studies.
We specialize in recruiting difficult-to-access patient populations, including those with type 1 and type 2 diabetes, stringent HbA1c criteria, lipid disorders, obesity, and rare endocrine conditions like Cushing's syndrome and acromegaly.
The Omega Research Advantage
Partner with Omega Research to leverage our integrated medical expertise, global regulatory knowledge, and operational excellence.
Custom Strategies
Developing custom strategies that expedite study start-up, enhance patient engagement, and generate the high-quality data needed to accelerate development and commercialization.
Global Network
Direct presence in Türkiye, TRNC, USA, and Kosovo, with partnerships in the EU and MENA, ensuring efficient and high-quality enrollment.
Difficult-to-Access Populations
Specialized in recruiting challenging patient populations including rare endocrine conditions like Cushing's syndrome and acromegaly.
Our Focus Areas
Our team's cumulative experience encompasses a wide range of study designs and patient populations across our global network.
Obesity & Weight Management
Comprehensive support for obesity and metabolic studies, including Phase IV and real-world evidence programs.
Diabetes Mellitus (Type 1 & Type 2)
Expertise in diabetes trials with stringent HbA1c criteria and complex monitoring protocols.
MASH
Metabolic Dysfunction-Associated Steatohepatitis studies including MASH-related cirrhosis.
Lipid Disorders & Dyslipidemia
Trials focused on novel lipid-lowering therapies and cardiovascular risk reduction.
Thyroid Disorders
Studies covering both hypo- and hyperthyroidism, including autoimmune thyroid conditions.
Rare Endocrine Diseases
Including Cushing's syndrome, acromegaly, and other rare endocrine conditions.
Comprehensive Medical, Regulatory & Operational Expertise
Therapeutically-Aligned Teams
Our core strength lies in our therapeutically-aligned teams. In-house medical experts and advanced clinical practitioners provide strategic input on study design, endpoint selection, and feasibility. They train operational staff, work directly with investigators, provide diligent medical monitoring, and support interactions with regulatory agencies (EMA, FDA, TİTCK).
Operational Excellence
Operationally, we pride ourselves on rapid study start-up, proactive risk-based monitoring, and successful recruitment and retention strategies tailored to endocrine and metabolic patient populations. Our regulatory affairs experts guide you through complex approval processes, leveraging our knowledge of both international and local requirements.
Obesity & Metabolic Disorder Expertise
Building on our extensive Phase IV and RWE experience, our medical, operational, and regulatory staff understand the intricacies of these trials from multiple perspectives — sponsor, patient, investigator, and regulator. Our mature relationships with global thought leaders, specialized investigative sites, and knowledge of effective patient retention strategies ensure efficient and high-quality enrollment.
Application Scenarios in the Omega Ecosystem
How the Omega ecosystem supports endocrine and metabolic research\u2014from HbA1c standardization to hormone assays and genetic profiling.
HelixLab
Glycemic & Lipid Panels
DCCT-aligned HbA1c with NGSP certification, fasting glucose, insulin, C-peptide, lipid profiles, and liver enzymes (ALT, AST, GGT) with protocol-driven sampling windows.
Omega Genetics
Monogenic Diabetes & MODY
Targeted gene panels for maturity-onset diabetes of the young (MODY: HNF1A, HNF4A, GCK), mitochondrial diabetes, and congenital hyperinsulinism molecular confirmation.
Omega Biorepository
Serial Sample Banking
Longitudinal plasma/serum storage for retrospective biomarker analysis in obesity and T2D trials, enabling future discovery of novel metabolic biomarkers.
Omega Care
Home Glucose & PRO Monitoring
Remote HbA1c and fasting glucose sampling; TURP platform integration for continuous glucose monitoring data upload and real-time patient-reported outcome capture.
Omega Bio
Hormone Assay Standardization
Kit-based harmonization for thyroid panel (TSH, fT3, fT4), cortisol, and IGF-1 assays ensuring lot-to-lot consistency across multi-country metabolic trials.
Animal Facility
Metabolic Disease Models
DIO (diet-induced obesity) mouse models, db/db and ob/ob diabetic models for preclinical efficacy and dose-finding before first-in-human metabolic studies.
Accelerate Your Endocrine & Metabolic Development
Partner with Omega Research for expert-driven clinical and real-world evidence programs.
Talk to Our Experts